Preview

Meditsinskiy sovet = Medical Council

Advanced search

Polyunsaturated fatty acid deficiency and pediatric neuropsychiatric morbidity

https://doi.org/10.21518/2079-701X-2020-18-173-178

Abstract

Child morbidity and disability is a national problem in any country, and measures to reduce it are the priority for every society. Recent years, children’s diseases such as neuropsychiatric diseases, (24,3%), nervous system diseases (22.9%); congenital anomalies (malformations), deformations and chromosomal disorders (16.2%). The absolute value of disabled children with nervous system diseases as of January 1, 2020 was 157,727.
At all stages of the nervous system formation, the process of cell membranes formation, covering both glial  cells and neurons themselves (and their branches - dendrites and axons), progresses actively. Cell membranes consist mainly of phospholipids, which are synthesized from long chain polyunsaturated fatty acids coming from food. In an attempt to determine the reasons for the growing disability of the child population, the researchers drew attention to the changed nature of the nutrition of society in general and the child population in particular over the past century. One of the significant components of the diet that affects the formation and development of the nervous system and the mental sphere were polyunsaturated fatty acids, some of which, with an unbalanced diet, can’t be obtained by the body from sources alternative to food. In this review, we observe the experience of correcting the nutritional status of young children and pregnant and lactating women with omega-3 polyunsaturated fatty acids. Numerous studies have confirmed the fact that there is a relationship between omega-3 polyunsaturated fatty acids deficiency, neurological deficiency and reduced intellectual abilities of a child.

About the Authors

O. V. Bykova
State Budgetary Healthcare Institution “Research and Clinical Center of Pediatric Psychoneurology” Moscow Healthcare Department; Federal State Autonomous Educational Institution of Higher Education “Peoples’ Friendship University of Russia”
Russian Federation

Dr. of Sci. (Med.), Pediatric neurologist, Head of the research Department; Professor of the Department of pediatric neurology, physical and rehabilitative medicine

74, Michurinsky Ave., Moscow, 119602, Russia

6, Miklukho-Maklai St., Moscow, 117198, Russia



Yu. A. Klimov
State Budgetary Healthcare Institution “Research and Clinical Center of Pediatric Psychoneurology” Moscow Healthcare Department
Russian Federation

Cand. of Sci. (Med.), Deputy Director

74, Michurinsky Ave., Moscow, 119602, Russia



S. V. Tikhonov
State Budgetary Healthcare Institution “Research and Clinical Center of Pediatric Psychoneurology” Moscow Healthcare Department
Russian Federation

Cand. of Sci. (Biol.), Senior Researcher

74, Michurinsky Ave., Moscow, 119602, Russia



S. S. Darina
State Budgetary Healthcare Institution “Research and Clinical Center of Pediatric Psychoneurology” Moscow Healthcare Department
Russian Federation

Neurologist, Head of the Psychoneurological Department No. 1

74, Michurinsky Ave., Moscow, 119602, Russia



References

1. Nikolaieva S.V., Usenko D.V., Shushakova E.K., Savvateieva O.A., Gorelov A.V. Omega-3 polyunsaturated fatty acids value for children. RMZh = RMJ. 2020;(2):28–32. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Znachenie_omega-3_polinenasyschennyh_ghirnyh_kislot_dlya_detey.

2. Kuzenkova L.M., Balkanskaya S.V., Uvakina E.V. The role of micronutrients and polyunsaturated fatty acids in preventing cognitive impairment in children with attention­deficit/hyperactivity disorder. Moscow; 2010. (In Russ.)

3. Gromova O.A., Torshin I.Yu., Sukhikh G.T., Baranov A.A., Prilepskaya V.N., Tetruashvili N.K., Uvarova E.V. Roles of various forms of omega­3 PUFAs in obstetrics and neonatology. Moscow; 2009. 64 p. (In Russ.)

4. Van Eijsden M., Hornstra G., van der Wal M.F., Vrijkotte T.G., Bonsel G.J. Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. Am J Clin Nutr. 2008;87(4):887–895. doi: 10.1093/ajcn/87.4.887.

5. Helland I.B., Saugstad O.D., Smith L., Saarem K., Solvoll K., Ganes T., Drevon C.A. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics. 2001;108(5):E82. doi: 10.1542/peds.108.5.e82.

6. Makrides M., Gibson R.A., McPhee A.J., Collins C.T., Davis P.G., Doyle L.W. et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA. 2009;301(2):175–182. doi: 10.1001/jama.2008.945.

7. Makarova S.G., Vishneva E.A. Modern views on the impact of long-chain polyunsaturated fatty acids on the development of the child’s nervous system. Voprosy sovremennoj pediatri = Current Pediatrics. 2015;14(1):55–63. (In Russ.) doi: 10.15690/vsp.v14i1.1263.

8. Belyaev E.N., Chiburaev V.I., Ivanov A.A., Platonova A.G., Markelova S.V. Characteristics of actual nutrition and health of children in the regions of the Russian Federation. Voprosy pitaniya = Problems of Nutrition. 2000;69(6):3–7. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=38242883.

9. Innis S.M. Dietary (n-3) fatty acids and brain development. J Nutr. 2007;137(4):855–859. doi: 10.1093/jn/137.4.855.

10. Kirby A., Woodward A., Jackson S., Wang Y., Crawford M.A. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8–10 years from a mainstream school population. Res Dev Disabil. 2010;31(3):718–730. doi: 10.1016/j.ridd.2010.01.014.

11. Rader R., McCauley L., Callen E.C. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder. Am Fam Physician. 2009;79(8):657–665. Available at: https://pubmed.ncbi.nlm.nih.gov/19405409.

12. Spahis S., Vanasse M., Belanger S.A., Ghadirian P., Grenier E., Levy E. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2008;79(1–2):47–53. doi: 10.1016/j.plefa.2008.07.005.

13. Kumar A., Butt N.A., Levenson A.S. Chapter 39 – Natural EpigeneticModifying Molecules in Medical Therapy. In: Tollefsbol T.O. (ed.) Medical Epigenetics. 2016, pp. 747–798. doi: 10.1016/B978-0-12-803239-8.00039-9.

14. Fuentes-Albero M., Martínez-Martínez M.I., Cauli O. Omega-3 Long-Chain Polyunsaturated Fatty Acids Intake in Children with Attention Deficit and Hyperactivity Disorder. Brain Sci. 2019;9(5):120. doi: 10.3390/brainsci9050120.

15. Anjos T., Altmäe S., Emmett P., Tiemeier H., Closa-Monasterolo R., Luque V. et al. Nutrition and neurodevelopment in children: focus on NUTRIMENTHE project. Eur J Nutr. 2013;52(8):1825–1842. doi: 10.1007/s00394-013-0560-4.

16. Meyer B.J., Mann N.J., Lewis J.L., Milligan G.C., Sinclair A.J., Howe P.R. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids. 2003;38(4):391–398. doi: 10.1007/s11745-003-1074-0.


Review

For citations:


Bykova OV, Klimov YA, Tikhonov SV, Darina SS. Polyunsaturated fatty acid deficiency and pediatric neuropsychiatric morbidity. Meditsinskiy sovet = Medical Council. 2020;(18):173-178. (In Russ.) https://doi.org/10.21518/2079-701X-2020-18-173-178

Views: 1073


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)